MHLW Warns Of Of Higher Risk Of Aggressive Behavior In Patients On Antidepressants
This article was originally published in PharmAsia News
Japan's Ministry of Health, Labor and Welfare June 24 called attention to SSRI and SNRI antidepressants. The ministry cited a higher risk of aggressive behaviors towards others and required physicians to use caution when prescriptions. The SSRI drugs currently available in Japan include Paxil (paroxetine), Luvox (fluvoxamine), Depromel (fluvoxamine) and Zoloft (sertraline). The most prescribed drug is Paxil with estimated annual prescriptions of 1.23 million. (Click here for more - Japanese language
You may also be interested in...
GNC announces "significant" store and management staff furloughs and other cost-cutting moves "to protect the long-term prospects for the business." Vitamin Shoppe told customers that its stores remain open though it reduced business hours.
California-based biosensor patch company LifeSignals Group plans to file for an emergency use authorization from the US FDA for a new patch that can monitor vital signs to help individuals decide when to seek the help of a health care provider. See what LifeSignals’ CEO Surendar Magar said about it here.
Following the US request for ranitidine drugs to be withdrawn from the market, the European Medicines Agency says it would decide the fate of the products in the EU after wrapping up its own inquiry.